January 28, 2005
Today Ferring Pharmaceuticals published an interview with Executive Chairman, Frederik Paulsen on its corporate website www.ferring.com . Mr. Paulsen talks about the present and what the future may hold for Ferring, but in particular about the Ferring Philosophy and why People come First at Ferring.
Ferring has grown rapidly and spread out so far across the globe that there is a risk of losing sight of the ideals upon which Ferring was founded - ideals that make the company unique. The Ferring Philosophy 'People come First' was introduced in January 2004 and encapsulates the ideals of Ferring's founders.
"It is my conviction and promise that our founder Dr. Frederik Paulsen's character and virtues, creativity, openness to the world, integrity, respect for others and commitment to conservative financial policies will not be lost in the pursuit of business success and will continue to define Ferring's corporate culture for the future,' stated Executive Chairman, Frederik Paulsen. 'As we go forward we will inevitably face difficult decisions from time to time. By applying the Ferring Philosophy I trust we will make the right choices".
The Ferring Philosophy, based as it is on respect for others and embodied in the concept that 'People come First at Ferring', will allow the company to retain its uniqueness through the years to come.
"We really have more than a moral obligation towards the people we treat and in terms of drug development we must do our best to secure the interest of the patients and produce products of the best quality," says Frederik Paulsen in the interview, which you can view on www.ferring.com . Here you can also find the Ferring Philosophy .
Ferring is a Swiss based research driven, speciality biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of urology, obstetrics and infertility, gastroenterology and endocrinology.
In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.
For more information, please contact:
Tel.: +45 28787198